Vanadis Core® qualitative assay for screening the risk of trisomy 21, 18, and/or 13.
Feature | Specification |
---|---|
Application | Noninvasive Prenatal Testing (NIPT) |
Vanadis Core® qualitative assay for screening the risk of trisomy 21, 18, and/or 13.
Qualitative assay intended for an in vitro diagnostic use to act as an aid in screening for the risk of trisomy 21, 18, and/or 13 in fetus using cell-free DNA from pregnant women of at least 10 weeks of gestation.
Application |
Noninvasive Prenatal Testing (NIPT)
|
---|---|
Brand |
Vanadis Core®
|
Disorders |
Common Trisomies
|
Instrument Compatibility |
Vanadis NIPT System
|
Sample Type |
Serum
|
Technology |
Rolling Circle Amplification (RCA)
|
Unit Size |
84 samples
|
Are you looking for resources, click on the resource type to explore further.
We are here to answer your questions.